Litigation Details for Impax Laboratories Inc. v. Lannett Holdings Inc. (D. Del. 2014)
✉ Email this page to a colleague
Impax Laboratories Inc. v. Lannett Holdings Inc. (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-07-25 |
| Court | District Court, D. Delaware | Date Terminated | 2017-04-17 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | IMPAX LABORATORIES INC.; LANNETT COMPANY INC. | ||
| Patents | 6,750,237; 7,220,767; 9,289,432 | ||
| Attorneys | Austen C. Endersby; Stefan M. Miller | ||
| Link to Docket | External link to docket | ||
Details for Impax Laboratories Inc. v. Lannett Holdings Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-10-11 | 140 | 1–16 of U.S. Patent No. 6,750,237 (the “’237 patent”) and claims 1–16 of U.S. Patent No. 7,220,767… Objections PX‐1 6/15/2004 Patent: U.S. Patent No. 6,750,237 B1, Issued to Dearn, et al. … the PX‐3 Patent: File History of U.S. Patent No. 6,750,237 … I. THE ASSERTED CLAIMS OF U.S. PATENT NOS. 6,750,237 AND 7,220,767 ARE NOT… Holdings, Inc. v. Astrazenca AB of U.S. Patent No. 6,750,237 to PX‐85 7/28/2015 Dearn et al. | External link to document | |
| 2017-04-19 | 175 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,750,237 B1; 7,220,767 B2. (…2014 17 April 2017 1:14-cv-00984 830 Patent None District Court, D. Delaware | External link to document | |
| 2014-07-25 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,750,237 B2; 7,220,767 B2. (…2014 17 April 2017 1:14-cv-00984 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
